scholarly journals 165TiP A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies

2021 ◽  
Vol 32 ◽  
pp. S1454
Author(s):  
E. Garralda ◽  
I. Melero ◽  
G. de Velasco ◽  
V. Moreno ◽  
H.K. Oberoi ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Bispecific Antibody ◽  
Advanced Malignancies

scholarly journals 1033TiP A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies

2021 ◽  
Vol 32 ◽  
pp. S864-S865
Author(s):  
K. Papadopoulos ◽  
T.A. Yap ◽  
S.A. Piha-Paul ◽  
P. Lorusso ◽  
S. Hu-Lieskovan ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Bispecific Antibody ◽  
Advanced Malignancies

scholarly journals Preliminary results from a phase I study of GBR 1302, a bispecific antibody T-cell engager, in HER2 positive cancers

2018 ◽  
Vol 29 ◽  
pp. viii408-viii409 ◽  
Author(s):  
M. Wermke ◽  
J. Alt ◽  
J. Kauh ◽  
J. Back ◽  
Y. Salhi ◽  
...  
Keyword(s):  
T Cell ◽  
Phase I ◽  
Phase I Study ◽  
Bispecific Antibody ◽  
Her2 Positive ◽  
Preliminary Results

Phase I study of liposome-encapsulated c-raf antisense oligodeoxyribonucleotide infusion in combination with radiation therapy in patients with advanced malignancies.

2006 ◽  
Vol 12 (4) ◽  
pp. 1251-1259 ◽  
Author(s):  
Anatoly Dritschilo ◽  
Chao H Huang ◽  
Charles M Rudin ◽  
John Marshall ◽  
Brian Collins ◽  
...  
Keyword(s):  
Radiation Therapy ◽  
Phase I ◽  
Phase I Study ◽  
Advanced Malignancies

Phase I study of cisdiamminedichloroplatinum in combination with azidothymidine in the treatment of patients with advanced malignancies

2003 ◽  
Vol 51 (6) ◽  
pp. 459-464 ◽  
Author(s):  
Robert J. Morgan ◽  
Edward M. Newman ◽  
Lawrence Sowers ◽  
Kevin Scanlon ◽  
Jonathan Harrison ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Advanced Malignancies

scholarly journals A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer

2018 ◽  
Vol 82 (3) ◽  
pp. 407-418 ◽  
Author(s):  
Amita Patnaik ◽  
Michael Gordon ◽  
Frank Tsai ◽  
Kyri Papadopoulous ◽  
Drew Rasco ◽  
...  
Keyword(s):  
Phase I ◽  
Phase I Study ◽  
Bispecific Antibody ◽  
Metastatic Cancer ◽  
Antibody Targeting
Sign in / Sign up

Export Citation Format

Share Document